v3.22.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current Assets    
Cash $ 341,284 $ 95,172
Accounts receivable 7,238 13,500
Patient financing receivable, current portion 55,200 43,900
Other receivables 3,831
Prepaid expenses 170,464 44,884
Total Current Assets 578,017 197,456
Property and equipment, net 35,196 38,374
Patient financing receivable, net of current portion 69,619 67,163
Other assets 18,413 18,412
Total assets 701,245 321,405
Current Liabilities    
Accounts payable 680,204 585,291
Accrued liabilities 150,253 164,680
Other current liabilities 139,570 28,246
Notes payable, current portion 69,455 69,455
Convertible notes payable, related parties 1,969,174 1,969,174
Convertible notes payable 1,355,826 1,355,826
PPP Loan, current portion 26,536 66,275
Deferred revenue 60,927 414,025
Lease liability, current portion 97,066 94,805
Interest payable, related parties 137,993 98,055
Interest payable 109,453 75,048
Total Current Liabilities 4,796,457 4,920,880
Long-term Liabilities    
Lease liability, net of current portion 37,753 62,768
Total Long-term Liabilities 37,753 62,768
Total Liabilities 4,834,210 4,983,648
Stockholders’ Equity (Deficit)    
Preferred Stock - $.001 par value:  1,000,000,000 shares authorized; Series A Preferred Stock - $.001 par value: 800,000,000 shares authorized, 498,229,804 and 501,887,534 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively. 498,229 501,887
Common stock - $.001 par value: 1,600,000,000 shares authorized, 251,436,818 and 164,199,792 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively. 251,437 164,199
Additional paid-in capital 48,037,565 43,700,084
Accumulated deficit (52,920,196) (49,028,413)
Total Stockholders’ Deficit (4,132,965) (4,662,243)
Total Liabilities and Stockholders’ Deficit $ 701,245 $ 321,405

Source